Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.65 USD
-0.10 (-5.71%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $1.69 +0.04 (2.42%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Biorestorative Therapies, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -14.42 | -18.49 | -44.30 | -11.27 | -14.65 |
Depreciation/Amortization & Depletion | 0.17 | 0.12 | 1.22 | 1.40 | 3.89 |
Net Change from Assets/Liabilities | 0.52 | 0.01 | 0.32 | 0.57 | 0.54 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.30 | 12.49 | 39.43 | 7.34 | 3.30 |
Net Cash From Operating Activities | -6.43 | -5.87 | -3.33 | -1.96 | -6.92 |
Property & Equipment | -0.17 | -0.27 | -0.03 | 0.00 | -0.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 3.42 | -13.04 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | -0.18 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 3.25 | -13.48 | -0.03 | 0.00 | -0.04 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.35 | 0.00 | 21.07 | 0.01 | 1.66 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.25 | 4.29 | 5.18 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.73 | 0.00 |
Net Cash from Financing Activities | 2.35 | 0.00 | 21.32 | 5.53 | 6.84 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -0.83 | -19.35 | 17.96 | 3.06 | -0.12 |
Cash at Beginning of Period | 1.71 | 21.03 | 3.06 | 0.00 | 0.12 |
Cash at End of Period | 0.89 | 1.68 | 21.03 | 3.06 | 0.00 |
Diluted Net EPS | -3.42 | -5.11 | -37.30 | -33.33 | -2,200.00 |
Fiscal Year End for Biorestorative Therapies, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.25 | -2.22 | -14.42 | -11.59 | -8.66 |
Depreciation/Amortization & Depletion | 0.09 | 0.04 | 0.17 | 0.12 | 0.08 |
Net Change from Assets/Liabilities | -0.28 | -0.48 | 0.52 | 0.39 | 0.24 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.26 | 0.34 | 7.30 | 6.42 | 4.86 |
Net Cash From Operating Activities | -4.18 | -2.32 | -6.43 | -4.66 | -3.48 |
Property & Equipment | -0.04 | 0.00 | -0.17 | 3.59 | -0.09 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -1.92 | -4.93 | 3.42 | -0.44 | 3.26 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -1.95 | -4.93 | 3.25 | 3.15 | 3.17 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 7.53 | 7.53 | 2.35 | 2.27 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.02 | -0.01 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.51 | 7.52 | 2.35 | 2.27 | 0.41 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 1.37 | 0.27 | -0.83 | 0.76 | 0.11 |
Cash at Beginning of Period | 0.88 | 0.88 | 1.71 | 1.68 | 1.68 |
Cash at End of Period | 2.25 | 1.16 | 0.89 | 2.44 | 1.78 |
Diluted Net EPS | -0.50 | -0.33 | -0.48 | -0.64 | -0.77 |